Search

Your search keyword '"Vos, Rimke C"' showing total 140 results
Start Over Author "Vos, Rimke C" Database OAIster
140 results on '"Vos, Rimke C"'

1. A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial

Author

Andriessen, Charlotte, Blom, Marieke T., van Hoek, Beryl A.C.E., de Boer, Anna W., Denig, Petra, de Wit, G. Ardine, Swart, Karin, de Rooij-Peek, Angela, van Marum, Rob J., Hugtenburg, Jacqueline G., Slottje, Pauline, van Raalte, Daniël, van Bloemendaal, Liselotte, Herings, Ron, Nijpels, Giel, Vos, Rimke C., Elders, Petra J.M., Andriessen, Charlotte, Blom, Marieke T., van Hoek, Beryl A.C.E., de Boer, Anna W., Denig, Petra, de Wit, G. Ardine, Swart, Karin, de Rooij-Peek, Angela, van Marum, Rob J., Hugtenburg, Jacqueline G., Slottje, Pauline, van Raalte, Daniël, van Bloemendaal, Liselotte, Herings, Ron, Nijpels, Giel, Vos, Rimke C., and Elders, Petra J.M.

Published
2024

2. Sex differences in body composition in people with prediabetes and type 2 diabetes as compared with people with normal glucose metabolism: the Maastricht Study

Author

Cardiovasculaire Epi Team 5, Cardiovasculaire Epidemiologie, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Team Onderzoek, de Ritter, Rianneke, Sep, Simone J.S., van Greevenbroek, Marleen M.J., Kusters, Yvo H.A.M., Vos, Rimke C., Bots, Michiel L., Kooi, M. Eline, Dagnelie, Pieter C., Eussen, Simone J.P.M., Schram, Miranda T., Koster, Annemarie, Brouwers, Martijn C.G., van der Sangen, Niels M.R., Peters, Sanne A.E., van der Kallen, Carla J.H., Stehouwer, Coen D.A., Cardiovasculaire Epi Team 5, Cardiovasculaire Epidemiologie, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Team Onderzoek, de Ritter, Rianneke, Sep, Simone J.S., van Greevenbroek, Marleen M.J., Kusters, Yvo H.A.M., Vos, Rimke C., Bots, Michiel L., Kooi, M. Eline, Dagnelie, Pieter C., Eussen, Simone J.P.M., Schram, Miranda T., Koster, Annemarie, Brouwers, Martijn C.G., van der Sangen, Niels M.R., Peters, Sanne A.E., van der Kallen, Carla J.H., and Stehouwer, Coen D.A.

Published
2023

3. Diabetes patient preferences for glucose-monitoring technologies: Results from a discrete choice experiment in Poland and the Netherlands

Author

Healthcare Innovation & Evaluation, HEE, HEE Team 1, Circulatory Health, JC onderzoeksprogramma Methodology, Smith, Ian P., Whichello, Chiara L., Veldwijk, Jorien, Rutten-Van Mölken, Maureen P.M.H., Groothuis-Oudshoorn, C. G.M., Vos, Rimke C., De Bekker-Grob, Esther W., De Wit, G. Ardine, Healthcare Innovation & Evaluation, HEE, HEE Team 1, Circulatory Health, JC onderzoeksprogramma Methodology, Smith, Ian P., Whichello, Chiara L., Veldwijk, Jorien, Rutten-Van Mölken, Maureen P.M.H., Groothuis-Oudshoorn, C. G.M., Vos, Rimke C., De Bekker-Grob, Esther W., and De Wit, G. Ardine

Published
2023

4. Diabetes patient preferences for glucose-monitoring technologies:results from a discrete choice experiment in Poland and the Netherlands

Author

Smith, Ian P, Whichello, Chiara Lauren, Veldwijk, Jorien, van Molken, Maureen, Groothuis-Oudshoorn, Catharina G.M., Vos, Rimke C, de Bekker-Grob, Esther, Ardine de Wit, G., Smith, Ian P, Whichello, Chiara Lauren, Veldwijk, Jorien, van Molken, Maureen, Groothuis-Oudshoorn, Catharina G.M., Vos, Rimke C, de Bekker-Grob, Esther, and Ardine de Wit, G.

Abstract

Introduction New glucose-monitoring technologies have different cost–benefit profiles compared with traditional finger-prick tests, resulting in a preference-sensitive situation for patients. This study aimed to assess the relative value adults with diabetes assign to device attributes in two countries. Research design and methods Adults with type 1 or 2 diabetes from the Netherlands (n=226) and Poland (n=261) completed an online discrete choice experiment. Respondents choose between hypothetical glucose monitors described using seven attributes: precision, effort to check, number of finger pricks required, risk of skin irritation, information provided, alarm function and out-of-pocket costs. Panel mixed logit models were used to determine attribute relative importance and to calculate expected uptake rates and willingness to pay (WTP). Results The most important attribute for both countries was monthly out-of-pocket costs. Polish respondents were more likely than Dutch respondents to choose a glucose-monitoring device over a standard finger prick and had higher WTP for a device. Dutch respondents had higher WTP for device improvements in an effort to check and reduce the number of finger pricks a device requires. Conclusion Costs are the primary concern of patients in both countries when choosing a glucose monitor and would likely hamper real-world uptake. The costs-benefit profiles of such devices should be critically reviewed.

Published
2023

7. Opinions on hypertension care and therapy adherence at the healthcare provider and healthcare system level: a qualitative study in the Hague, Netherlands

Author

Cardiovasculaire Epi Team 5, Cardiovasculaire Epidemiologie, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Zorginnovatieonderzoek, Van Grondelle, Saskia E., Van Bruggen, Sytske, Meijer, Judith, Van Duin, Erik, Bots, Michiel L., Rutten, Guy, Vos, Hedwig M.M., Numans, Mattijs E., Vos, Rimke C., Cardiovasculaire Epi Team 5, Cardiovasculaire Epidemiologie, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Zorginnovatieonderzoek, Van Grondelle, Saskia E., Van Bruggen, Sytske, Meijer, Judith, Van Duin, Erik, Bots, Michiel L., Rutten, Guy, Vos, Hedwig M.M., Numans, Mattijs E., and Vos, Rimke C.

Published
2022

8. Shared decision making in primary care: Process evaluation of the intervention in the OPTIMAL study, a cluster randomised trial

Author

HAG Hart- Vaatziekten, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiovasculaire Epi Team 5, HAG Zorginnovatieonderzoek, Den Ouden, Henk, Vos, Rimke C., Pieterse, Arwen H., Rutten, Guy E.H.M., HAG Hart- Vaatziekten, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiovasculaire Epi Team 5, HAG Zorginnovatieonderzoek, Den Ouden, Henk, Vos, Rimke C., Pieterse, Arwen H., and Rutten, Guy E.H.M.

Published
2022

9. Effectiveness of the Beyond Good Intentions Program on Improving Dietary Quality Among People With Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Author

HAG Zorginnovatieonderzoek, Huisartsopleiding Jaar 1, Cardiovasculaire Epi Team 5, van der Velde, Laura A., Kiefte-de Jong, Jessica C., Rutten, Guy E., Vos, Rimke C., HAG Zorginnovatieonderzoek, Huisartsopleiding Jaar 1, Cardiovasculaire Epi Team 5, van der Velde, Laura A., Kiefte-de Jong, Jessica C., Rutten, Guy E., and Vos, Rimke C.

Published
2021

10. Association of weight loss and weight loss maintenance following diabetes diagnosis by screening and incidence of cardiovascular disease and all-cause mortality: An observational analysis of the ADDITION-Europe trial

Author

Cardiovasculaire Epi Team 5, HAG Zorginnovatieonderzoek, Strelitz, Jean, Sharp, Stephen J., Khunti, Kamlesh, Vos, Rimke C., Rutten, Guy E.H.M., Webb, David R., Witte, Daniel R., Sandbæk, Annelli, Wareham, Nicholas J., Griffin, Simon J., Cardiovasculaire Epi Team 5, HAG Zorginnovatieonderzoek, Strelitz, Jean, Sharp, Stephen J., Khunti, Kamlesh, Vos, Rimke C., Rutten, Guy E.H.M., Webb, David R., Witte, Daniel R., Sandbæk, Annelli, Wareham, Nicholas J., and Griffin, Simon J.

Published
2021

11. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study

Author

de Ritter, Rianneke, Sep, Simone J.S., van der Kallen, Carla J.H., van Greevenbroek, Marleen M.J., de Jong, Marit, Vos, Rimke C., Bots, Michiel L., Reulen, Jos P.H., Houben, Alfons J.H.M., Webers, Carroll A.B., Berendschot, Tos T.J.M., Dagnelie, Pieter C., Eussen, Simone J.P.M., Schram, Miranda T., Koster, Annemarie, Peters, Sanne A.E., Stehouwer, Coen D.A., de Ritter, Rianneke, Sep, Simone J.S., van der Kallen, Carla J.H., van Greevenbroek, Marleen M.J., de Jong, Marit, Vos, Rimke C., Bots, Michiel L., Reulen, Jos P.H., Houben, Alfons J.H.M., Webers, Carroll A.B., Berendschot, Tos T.J.M., Dagnelie, Pieter C., Eussen, Simone J.P.M., Schram, Miranda T., Koster, Annemarie, Peters, Sanne A.E., and Stehouwer, Coen D.A.

Abstract

Background Women with type 2 diabetes are disproportionally affected by macrovascular complications; we here investigated whether this is also the case for microvascular complications and retinal microvascular measures. Methods In a population-based cohort study of individuals aged 40–75 years (n = 3410; 49% women, 29% type 2 diabetes (oversampled by design)), we estimated sex-specific associations, and differences therein, of (pre)diabetes (reference: normal glucose metabolism), and of continuous measures of glycemia with microvascular complications and retinal measures (nephropathy, sensory neuropathy, and retinal arteriolar and venular diameters and dilatation). Sex differences were analyzed using regression models with interaction terms (i.e. sex-by- (pre)diabetes and sex-by-glycemia) and were adjusted for potential confounders. Results Men with type 2 diabetes (but not those with prediabetes) compared to men with normal glucose metabolism, (and men with higher levels of glycemia), had significantly higher prevalences of nephropathy (odds ratio: 1.58 95% CI (1.01;2.46)) and sensory neuropathy (odds ratio: 2.46 (1.67;3.63)), larger retinal arteriolar diameters (difference: 4.29 µm (1.22;7.36)) and less retinal arteriolar dilatation (difference: − 0.74% (− 1.22; − 0.25)). In women, these associations were numerically in the same direction, but generally not statistically significant (odds ratios: 1.71 (0.90;3.25) and 1.22 (0.75;1.98); differences: 0.29 µm (− 3.50;4.07) and: − 0.52% (− 1.11;0.08), respectively). Interaction analyses revealed no consistent pattern of sex differences in the associations of either prediabetes or type 2 diabetes or glycemia with microvascular complications or retinal measures. The prevalence of advanced-stage complications was too low for evaluation. Conclusions Our findings show that women with type 2 diabetes are not disproportionately affected by early microvascular complications.

Published
2021

12. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study

Author

de Ritter, Rianneke, Sep, Simone J.S., van der Kallen, Carla J.H., van Greevenbroek, Marleen M.J., de Jong, Marit, Vos, Rimke C., Bots, Michiel L., Reulen, Jos P.H., Houben, Alfons J.H.M., Webers, Carroll A.B., Berendschot, Tos T.J.M., Dagnelie, Pieter C., Eussen, Simone J.P.M., Schram, Miranda T., Koster, Annemarie, Peters, Sanne A.E., Stehouwer, Coen D.A., de Ritter, Rianneke, Sep, Simone J.S., van der Kallen, Carla J.H., van Greevenbroek, Marleen M.J., de Jong, Marit, Vos, Rimke C., Bots, Michiel L., Reulen, Jos P.H., Houben, Alfons J.H.M., Webers, Carroll A.B., Berendschot, Tos T.J.M., Dagnelie, Pieter C., Eussen, Simone J.P.M., Schram, Miranda T., Koster, Annemarie, Peters, Sanne A.E., and Stehouwer, Coen D.A.

Abstract

Background Women with type 2 diabetes are disproportionally affected by macrovascular complications; we here investigated whether this is also the case for microvascular complications and retinal microvascular measures. Methods In a population-based cohort study of individuals aged 40–75 years (n = 3410; 49% women, 29% type 2 diabetes (oversampled by design)), we estimated sex-specific associations, and differences therein, of (pre)diabetes (reference: normal glucose metabolism), and of continuous measures of glycemia with microvascular complications and retinal measures (nephropathy, sensory neuropathy, and retinal arteriolar and venular diameters and dilatation). Sex differences were analyzed using regression models with interaction terms (i.e. sex-by- (pre)diabetes and sex-by-glycemia) and were adjusted for potential confounders. Results Men with type 2 diabetes (but not those with prediabetes) compared to men with normal glucose metabolism, (and men with higher levels of glycemia), had significantly higher prevalences of nephropathy (odds ratio: 1.58 95% CI (1.01;2.46)) and sensory neuropathy (odds ratio: 2.46 (1.67;3.63)), larger retinal arteriolar diameters (difference: 4.29 µm (1.22;7.36)) and less retinal arteriolar dilatation (difference: − 0.74% (− 1.22; − 0.25)). In women, these associations were numerically in the same direction, but generally not statistically significant (odds ratios: 1.71 (0.90;3.25) and 1.22 (0.75;1.98); differences: 0.29 µm (− 3.50;4.07) and: − 0.52% (− 1.11;0.08), respectively). Interaction analyses revealed no consistent pattern of sex differences in the associations of either prediabetes or type 2 diabetes or glycemia with microvascular complications or retinal measures. The prevalence of advanced-stage complications was too low for evaluation. Conclusions Our findings show that women with type 2 diabetes are not disproportionately affected by early microvascular complications.

Published
2021

13. Sex Disparities in Cardiovascular Risk Factor Assessment and Screening for Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review

Author

Cardiovasculaire Epi Team 5, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Global Health, Circulatory Health, Cardiovasculaire Epidemiologie, de Jong, Marit, Peters, Sanne A.E., de Ritter, Rianneke, van der Kallen, Carla J.H., Sep, Simone J.S., Woodward, Mark, Stehouwer, Coen D.A., Bots, Michiel L., Vos, Rimke C., Cardiovasculaire Epi Team 5, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Global Health, Circulatory Health, Cardiovasculaire Epidemiologie, de Jong, Marit, Peters, Sanne A.E., de Ritter, Rianneke, van der Kallen, Carla J.H., Sep, Simone J.S., Woodward, Mark, Stehouwer, Coen D.A., Bots, Michiel L., and Vos, Rimke C.

Published
2021

14. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study

Author

Cardiovasculaire Epi Team 5, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiovasculaire Epidemiologie, Circulatory Health, Global Health, de Ritter, Rianneke, Sep, Simone J.S., van der Kallen, Carla J.H., van Greevenbroek, Marleen M.J., de Jong, Marit, Vos, Rimke C., Bots, Michiel L., Reulen, Jos P.H., Houben, Alfons J.H.M., Webers, Carroll A.B., Berendschot, Tos T.J.M., Dagnelie, Pieter C., Eussen, Simone J.P.M., Schram, Miranda T., Koster, Annemarie, Peters, Sanne A.E., Stehouwer, Coen D.A., Cardiovasculaire Epi Team 5, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiovasculaire Epidemiologie, Circulatory Health, Global Health, de Ritter, Rianneke, Sep, Simone J.S., van der Kallen, Carla J.H., van Greevenbroek, Marleen M.J., de Jong, Marit, Vos, Rimke C., Bots, Michiel L., Reulen, Jos P.H., Houben, Alfons J.H.M., Webers, Carroll A.B., Berendschot, Tos T.J.M., Dagnelie, Pieter C., Eussen, Simone J.P.M., Schram, Miranda T., Koster, Annemarie, Peters, Sanne A.E., and Stehouwer, Coen D.A.

Published
2021

15. Type 2 diabetes and COPD: treatment in the right healthcare setting? An observational study

Author

Cardiovasculaire Epi Team 5, Huisartsopleiding, Circulatory Health, JC onderzoeksprogramma Cardiovascular Health, Willink, R P, Vos, Rimke C, Looijmans-van den Akker, I, Hart, Huberta E, Cardiovasculaire Epi Team 5, Huisartsopleiding, Circulatory Health, JC onderzoeksprogramma Cardiovascular Health, Willink, R P, Vos, Rimke C, Looijmans-van den Akker, I, and Hart, Huberta E

Published
2021

16. The impact of the new Dutch guideline on cardiovascular risk management in patients with COPD: a retrospective study

Author

Cardiovasculaire Epi Team 5, Huisartsopleiding, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Nies, Lonneke Me, Akker, Ingrid Looijmans-van den, Rozendaal, Liesbeth, Baar, Brenda, Vos, Rimke C, Hart, Huberta E, Cardiovasculaire Epi Team 5, Huisartsopleiding, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Nies, Lonneke Me, Akker, Ingrid Looijmans-van den, Rozendaal, Liesbeth, Baar, Brenda, Vos, Rimke C, and Hart, Huberta E

Published
2021

17. Discussing overweight in children during a regular consultation in general practice: a qualitative study

Author

van der Maas, Joline C, Corbee, Ronald J, Kroese, Floor M, de Ridder, Denise T D, Vos, Rimke C, Nielen, Mirjam, Monninkhof, Evelyn, van der Maas, Joline C, Corbee, Ronald J, Kroese, Floor M, de Ridder, Denise T D, Vos, Rimke C, Nielen, Mirjam, and Monninkhof, Evelyn

Abstract

BACKGROUND: Overweight in children is a rising problem leading to serious consequences later in life. The Dutch guideline 'Obesity' for general practitioners recommends discussing obesity in children regardless of the reason of consultation and provides diagnostic and therapeutic tools. However, limited literature indicates that general practitioners experience barriers to discuss this topic. The aim of this study was to determine current perceived barriers of general practitioners in discussing overweight during a regular consultation in children aged 4 to 12 years and to what extent they discuss the topic. Furthermore, we attempt to get more insight in the specific needs and ideas for improvement among GPs.METHODS: A semi-structured in-depth interview study was conducted. Dutch general practitioners with a broad range of demographic characteristics were invited to participate. The transcripts were analysed using a modified version of the constant comparative method. Using this method, we identified perceived barriers of general practitioners.RESULTS: Ten general practitioners were included in the study. Four major themes were identified in the interviews: absence of physical or mental complaints related to overweight, internal barriers of the general practitioners, the child's family background and logistics. Major barriers appeared to be a low consultation rate of these children, the sensitivity of the topic (e.g. fear for children's or parents' reactions and/or disturbance of the relation, influence on the self-esteem of the child, resistance in the parents), the absence of a long-standing relation between general practitioner and child or parent, the background of the child and lack of time or prioritizing.CONCLUSION: Dutch general practitioners indicate to experience barriers and need tools for how to discuss children's overweight during regular consultations within the limited time available. The low consultation rate among children ag

Published
2020

18. Discussing overweight in children during a regular consultation in general practice: a qualitative study

Author

Chirurgie, dCSCA AVR, Leerstoel Ridder, FAH Evidence based Veterinary Medicine, dFAH AVR, Stress and self-regulation, CS_Welfare & emerging diseases, van der Maas, Joline C, Corbee, Ronald J, Kroese, Floor M, de Ridder, Denise T D, Vos, Rimke C, Nielen, Mirjam, Monninkhof, Evelyn, Chirurgie, dCSCA AVR, Leerstoel Ridder, FAH Evidence based Veterinary Medicine, dFAH AVR, Stress and self-regulation, CS_Welfare & emerging diseases, van der Maas, Joline C, Corbee, Ronald J, Kroese, Floor M, de Ridder, Denise T D, Vos, Rimke C, Nielen, Mirjam, and Monninkhof, Evelyn

Published
2020

19. Discussing overweight in children during a regular consultation in general practice: a qualitative study

Author

Chirurgie, dCSCA AVR, Leerstoel Ridder, FAH Evidence based Veterinary Medicine, dFAH AVR, Stress and self-regulation, CS_Welfare & emerging diseases, van der Maas, Joline C, Corbee, Ronald J, Kroese, Floor M, de Ridder, Denise T D, Vos, Rimke C, Nielen, Mirjam, Monninkhof, Evelyn, Chirurgie, dCSCA AVR, Leerstoel Ridder, FAH Evidence based Veterinary Medicine, dFAH AVR, Stress and self-regulation, CS_Welfare & emerging diseases, van der Maas, Joline C, Corbee, Ronald J, Kroese, Floor M, de Ridder, Denise T D, Vos, Rimke C, Nielen, Mirjam, and Monninkhof, Evelyn

Published
2020

20. Population-based screen-detected type 2 diabetes mellitus is associated with less need for insulin therapy after 10 years

Author

UMC Utrecht Academie, Cardiovasculaire Epi Team 5, HAG Hart- Vaatziekten, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Fysica Radiotherapie Research, HAG Zorginnovatieonderzoek, Vos, Rimke C., Den Ouden, Henk, Daamen, Lois A., Bilo, Henk J.G., Denig, Petra, Rutten, Guy E.H.M., UMC Utrecht Academie, Cardiovasculaire Epi Team 5, HAG Hart- Vaatziekten, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Fysica Radiotherapie Research, HAG Zorginnovatieonderzoek, Vos, Rimke C., Den Ouden, Henk, Daamen, Lois A., Bilo, Henk J.G., Denig, Petra, and Rutten, Guy E.H.M.

Published
2020

22. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men : The Maastricht Study

Author

De Ritter, Rianneke, Sep, Simone J.S., Van Der Kallen, Carla J.H., Schram, Miranda T., Koster, Annemarie, Kroon, Abraham A., Van Greevenbroek, Marleen M.J., Eussen, Simone J.P.M., Dagnelie, Pieter C., De Jong, Marit, Vos, Rimke C., Woodward, Mark, Bots, Michiel L., Peters, Sanne A.E., Stehouwer, Coen D.A., De Ritter, Rianneke, Sep, Simone J.S., Van Der Kallen, Carla J.H., Schram, Miranda T., Koster, Annemarie, Kroon, Abraham A., Van Greevenbroek, Marleen M.J., Eussen, Simone J.P.M., Dagnelie, Pieter C., De Jong, Marit, Vos, Rimke C., Woodward, Mark, Bots, Michiel L., Peters, Sanne A.E., and Stehouwer, Coen D.A.

Published
2019

25. The effectiveness of an emotion-focused educational programme in reducing diabetes distress in adults with type 2 diabetes mellitus at 12-month follow-up : a cluster randomized controlled trial

Author

Chew, Boon How, Vos, Rimke C., Fernandez, Aaron, Shariff Ghazali, Sazlina, Shamsuddin, Nurainul Hana, Ismail, Mastura, Rutten, Guy E.H.M., Chew, Boon How, Vos, Rimke C., Fernandez, Aaron, Shariff Ghazali, Sazlina, Shamsuddin, Nurainul Hana, Ismail, Mastura, and Rutten, Guy E.H.M.

Published
2019

26. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care : 10-year follow-up of the ADDITION-Europe cluster-randomised trial

Author

Griffin, Simon J., Rutten, Guy E.H.M., Khunti, Kamlesh, Witte, Daniel R., Lauritzen, Torsten, Sharp, Stephen J., Dalsgaard, Else Marie, Davies, Melanie J., Irving, Greg J., Vos, Rimke C., Webb, David R., Wareham, Nicholas J., Sandbæk, Annelli, Griffin, Simon J., Rutten, Guy E.H.M., Khunti, Kamlesh, Witte, Daniel R., Lauritzen, Torsten, Sharp, Stephen J., Dalsgaard, Else Marie, Davies, Melanie J., Irving, Greg J., Vos, Rimke C., Webb, David R., Wareham, Nicholas J., and Sandbæk, Annelli

Published
2019

29. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care : 10-year follow-up of the ADDITION-Europe cluster-randomised trial

Author

Griffin, Simon J., Rutten, Guy E.H.M., Khunti, Kamlesh, Witte, Daniel R., Lauritzen, Torsten, Sharp, Stephen J., Dalsgaard, Else Marie, Davies, Melanie J., Irving, Greg J., Vos, Rimke C., Webb, David R., Wareham, Nicholas J., Sandbæk, Annelli, Griffin, Simon J., Rutten, Guy E.H.M., Khunti, Kamlesh, Witte, Daniel R., Lauritzen, Torsten, Sharp, Stephen J., Dalsgaard, Else Marie, Davies, Melanie J., Irving, Greg J., Vos, Rimke C., Webb, David R., Wareham, Nicholas J., and Sandbæk, Annelli

Published
2019

30. The effectiveness of an emotion-focused educational programme in reducing diabetes distress in adults with type 2 diabetes mellitus at 12-month follow-up : a cluster randomized controlled trial

Author

Chew, Boon How, Vos, Rimke C., Fernandez, Aaron, Shariff Ghazali, Sazlina, Shamsuddin, Nurainul Hana, Ismail, Mastura, Rutten, Guy E.H.M., Chew, Boon How, Vos, Rimke C., Fernandez, Aaron, Shariff Ghazali, Sazlina, Shamsuddin, Nurainul Hana, Ismail, Mastura, and Rutten, Guy E.H.M.

Published
2019

31. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men : The Maastricht Study

Author

De Ritter, Rianneke, Sep, Simone J.S., Van Der Kallen, Carla J.H., Schram, Miranda T., Koster, Annemarie, Kroon, Abraham A., Van Greevenbroek, Marleen M.J., Eussen, Simone J.P.M., Dagnelie, Pieter C., De Jong, Marit, Vos, Rimke C., Woodward, Mark, Bots, Michiel L., Peters, Sanne A.E., Stehouwer, Coen D.A., De Ritter, Rianneke, Sep, Simone J.S., Van Der Kallen, Carla J.H., Schram, Miranda T., Koster, Annemarie, Kroon, Abraham A., Van Greevenbroek, Marleen M.J., Eussen, Simone J.P.M., Dagnelie, Pieter C., De Jong, Marit, Vos, Rimke C., Woodward, Mark, Bots, Michiel L., Peters, Sanne A.E., and Stehouwer, Coen D.A.

Published
2019

34. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial

Author

Griffin, Simon J, Rutten, Guy E H M, Khunti, Kamlesh, Witte, Daniel R, Lauritzen, Torsten, Sharp, Stephen J, Dalsgaard, Else-Marie, Davies, Melanie J, Irving, Greg J, Vos, Rimke C, Webb, David R, Wareham, Nicholas J, Sandbæk, Annelli, Griffin, Simon J, Rutten, Guy E H M, Khunti, Kamlesh, Witte, Daniel R, Lauritzen, Torsten, Sharp, Stephen J, Dalsgaard, Else-Marie, Davies, Melanie J, Irving, Greg J, Vos, Rimke C, Webb, David R, Wareham, Nicholas J, and Sandbæk, Annelli

Abstract

BACKGROUND: The multicentre, international ADDITION-Europe study investigated the effect of promoting intensive treatment of multiple risk factors among people with screen-detected type 2 diabetes over 5 years. Here we report the results of a post-hoc 10-year follow-up analysis of ADDITION-Europe to establish whether differences in treatment and cardiovascular risk factors have been maintained and to assess effects on cardiovascular outcomes.METHODS: As previously described, general practices from four centres (Denmark, Cambridge [UK], Leicester [UK], and the Netherlands) were randomly assigned by computer-generated list to provide screening followed by routine care of diabetes, or screening followed by intensive multifactorial treatment. Population-based stepwise screening programmes among people aged 40-69 years (50-69 years in the Netherlands), between April, 2001, and December, 2006, identified patients with type 2 diabetes. Allocation was concealed from patients. Following the 5-year follow-up, no attempts were made to maintain differences in treatment between study groups. In this report, we did a post-hoc analysis of cardiovascular and renal outcomes over 10 years following randomisation, including a 5 years post-intervention follow-up. As in the original trial, the primary endpoint was a composite of first cardiovascular event, including cardiovascular mortality, cardiovascular morbidity (non-fatal myocardial infarction and non-fatal stroke), revascularisation, and non-traumatic amputation, up to Dec 31, 2014. Analyses were based on the intention-to-treat principle. ADDITION-Europe is registered with ClinicalTrials.gov, NCT00237549.FINDINGS: 343 general practices were randomly assigned to routine diabetes care (n=176) or intensive multifactorial treatment (n=167). 317 of these general practices (157 in the routine care group, 161 in the intensive treatment group) included eligible patients between April, 2001, and December, 2006. Of the 3233

Published
2019

38. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men : The Maastricht Study

Author

De Ritter, Rianneke, Sep, Simone J.S., Van Der Kallen, Carla J.H., Schram, Miranda T., Koster, Annemarie, Kroon, Abraham A., Van Greevenbroek, Marleen M.J., Eussen, Simone J.P.M., Dagnelie, Pieter C., De Jong, Marit, Vos, Rimke C., Woodward, Mark, Bots, Michiel L., Peters, Sanne A.E., Stehouwer, Coen D.A., De Ritter, Rianneke, Sep, Simone J.S., Van Der Kallen, Carla J.H., Schram, Miranda T., Koster, Annemarie, Kroon, Abraham A., Van Greevenbroek, Marleen M.J., Eussen, Simone J.P.M., Dagnelie, Pieter C., De Jong, Marit, Vos, Rimke C., Woodward, Mark, Bots, Michiel L., Peters, Sanne A.E., and Stehouwer, Coen D.A.

Published
2019

41. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care : 10-year follow-up of the ADDITION-Europe cluster-randomised trial

Author

Griffin, Simon J., Rutten, Guy E.H.M., Khunti, Kamlesh, Witte, Daniel R., Lauritzen, Torsten, Sharp, Stephen J., Dalsgaard, Else Marie, Davies, Melanie J., Irving, Greg J., Vos, Rimke C., Webb, David R., Wareham, Nicholas J., Sandbæk, Annelli, Griffin, Simon J., Rutten, Guy E.H.M., Khunti, Kamlesh, Witte, Daniel R., Lauritzen, Torsten, Sharp, Stephen J., Dalsgaard, Else Marie, Davies, Melanie J., Irving, Greg J., Vos, Rimke C., Webb, David R., Wareham, Nicholas J., and Sandbæk, Annelli

Published
2019

42. The effectiveness of an emotion-focused educational programme in reducing diabetes distress in adults with type 2 diabetes mellitus at 12-month follow-up : a cluster randomized controlled trial

Author

Chew, Boon How, Vos, Rimke C., Fernandez, Aaron, Shariff Ghazali, Sazlina, Shamsuddin, Nurainul Hana, Ismail, Mastura, Rutten, Guy E.H.M., Chew, Boon How, Vos, Rimke C., Fernandez, Aaron, Shariff Ghazali, Sazlina, Shamsuddin, Nurainul Hana, Ismail, Mastura, and Rutten, Guy E.H.M.

Published
2019

43. De-Intensification Of Blood Glucose Lowering Medication In People Identified As Being Over-Treated: A Mixed Methods Study

Author

Hart,Huberta E, Ditzel,Kim, Rutten,Guy E, de Groot,Esther, Seidu,Samuel, Khunti,Kamlesh, Vos,Rimke C, Hart,Huberta E, Ditzel,Kim, Rutten,Guy E, de Groot,Esther, Seidu,Samuel, Khunti,Kamlesh, and Vos,Rimke C

Abstract

Huberta E Hart,1,2,* Kim Ditzel,1,* Guy E Rutten,1 Esther de Groot,1 Samuel Seidu,3 Kamlesh Khunti,3 Rimke C Vos1,4 1Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, Utrecht, The Netherlands; 2Leidsche Rijn Julius Health Centers, Utrecht, The Netherlands; 3Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK; 4Department of Public Health and Primary Care/lumc-Campus the Hague, Leiden University Medical Center, The Hague, The Netherlands*These authors contributed equally to this workCorrespondence: Huberta E HartJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Erasmuslaan 68, Zeist 3707 ZE, The NetherlandsTel +31 6 1695 0844Email h.e.hart@umcutrecht.nlAim: To evaluate if, one year after notification of possible overtreatment, diabetes care providers de-intensified glucose-lowering medications and to gain insight into the opinions and beliefs of both care providers and patients regarding de-intensification.Methods: Mixed methods using routine care data from five health-care centres in the Netherlands. Patient characteristics and medication prescription of patients, previously identified as possibly over-treated, were extracted from patients’ medical records. Opinions of care providers were obtained through interviews. Patients received questionnaires about their diabetes treatment and were asked to participate in focus groups.Results: A total of 64 elderly patients with type 2 diabetes were previously identified as possibly over-treated and included; 57.8% male, median age 75 years (IQR=72–82), median diabetes duration 12 years (IQR=8–18). De-intensification was implemented in more than half (n=36) of them. Care providers preferred person-centred care above just setting general HbA1c target values, considering patient characteristics (such as comorbidity) and patient’s preference. Patients valued glucos

Published
2019

44. Effectiveness of diabetes self-management education and support via a smartphone application in insulin-treated patients with type 2 diabetes: Results of a randomized controlled trial (TRIGGER study)

Author

Cardiovasculaire Epi Team 5, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Hart- Vaatziekten, HAG Zorginnovatieonderzoek, Boels, Anne Meike, Vos, Rimke C., Dijkhorst-Oei, Lioe Ting, Rutten, Guy E.H.M., Cardiovasculaire Epi Team 5, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Hart- Vaatziekten, HAG Zorginnovatieonderzoek, Boels, Anne Meike, Vos, Rimke C., Dijkhorst-Oei, Lioe Ting, and Rutten, Guy E.H.M.

Published
2019

45. The effectiveness of an emotion-focused educational programme in reducing diabetes distress in adults with type 2 diabetes mellitus at 12-month follow-up: a cluster randomized controlled trial

Author

HAG Diabetes, HAG Hart- Vaatziekten, Other research (not in main researchprogram), JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Zorginnovatieonderzoek, Chew, Boon How, Vos, Rimke C., Fernandez, Aaron, Shariff Ghazali, Sazlina, Shamsuddin, Nurainul Hana, Ismail, Mastura, Rutten, Guy E.H.M., HAG Diabetes, HAG Hart- Vaatziekten, Other research (not in main researchprogram), JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Zorginnovatieonderzoek, Chew, Boon How, Vos, Rimke C., Fernandez, Aaron, Shariff Ghazali, Sazlina, Shamsuddin, Nurainul Hana, Ismail, Mastura, and Rutten, Guy E.H.M.

Published
2019

46. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial

Author

HAG Zorginnovatieonderzoek, HAG Hart- Vaatziekten, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Griffin, Simon J., Rutten, Guy E.H.M., Khunti, Kamlesh, Witte, Daniel R., Lauritzen, Torsten, Sharp, Stephen J., Dalsgaard, Else Marie, Davies, Melanie J., Irving, Greg J., Vos, Rimke C., Webb, David R., Wareham, Nicholas J., Sandbæk, Annelli, HAG Zorginnovatieonderzoek, HAG Hart- Vaatziekten, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Griffin, Simon J., Rutten, Guy E.H.M., Khunti, Kamlesh, Witte, Daniel R., Lauritzen, Torsten, Sharp, Stephen J., Dalsgaard, Else Marie, Davies, Melanie J., Irving, Greg J., Vos, Rimke C., Webb, David R., Wareham, Nicholas J., and Sandbæk, Annelli

Published
2019

47. De-intensification of blood glucose lowering medication in people identified as being over-treated: A mixed methods study

Author

Huisartsopleiding, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Zorginnovatieonderzoek, HAG Diabetes, JC Overig onderzoek, HAG Hart- Vaatziekten, Other research (not in main researchprogram), Hart, Huberta E., Ditzel, Kim, Rutten, Guy E., de Groot, Esther, Seidu, Samuel, Khunti, Kamlesh, Vos, Rimke C., Huisartsopleiding, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Zorginnovatieonderzoek, HAG Diabetes, JC Overig onderzoek, HAG Hart- Vaatziekten, Other research (not in main researchprogram), Hart, Huberta E., Ditzel, Kim, Rutten, Guy E., de Groot, Esther, Seidu, Samuel, Khunti, Kamlesh, and Vos, Rimke C.

Published
2019

48. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: The Maastricht Study

Author

Cardiovasculaire Epi Team 5, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Hart- Vaatziekten, Circulatory Health, De Ritter, Rianneke, Sep, Simone J.S., Van Der Kallen, Carla J.H., Schram, Miranda T., Koster, Annemarie, Kroon, Abraham A., Van Greevenbroek, Marleen M.J., Eussen, Simone J.P.M., Dagnelie, Pieter C., De Jong, Marit, Vos, Rimke C., Woodward, Mark, Bots, Michiel L., Peters, Sanne A.E., Stehouwer, Coen D.A., Cardiovasculaire Epi Team 5, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Hart- Vaatziekten, Circulatory Health, De Ritter, Rianneke, Sep, Simone J.S., Van Der Kallen, Carla J.H., Schram, Miranda T., Koster, Annemarie, Kroon, Abraham A., Van Greevenbroek, Marleen M.J., Eussen, Simone J.P.M., Dagnelie, Pieter C., De Jong, Marit, Vos, Rimke C., Woodward, Mark, Bots, Michiel L., Peters, Sanne A.E., and Stehouwer, Coen D.A.

Published
2019

49. A simple to implement and low-cost supervised walking programme in highly motivated individuals with or at risk for type 2 diabetes: An observational study with a pre-post design

Author

HAG Zorginnovatieonderzoek, HAG Diabetes, Huisartsopleiding, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Hart- Vaatziekten, Hoogendoorn, Sonja W., Rutten, Guy E.H.M., Hart, Huberta E., de Wolf, Cees, Vos, Rimke C., HAG Zorginnovatieonderzoek, HAG Diabetes, Huisartsopleiding, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Hart- Vaatziekten, Hoogendoorn, Sonja W., Rutten, Guy E.H.M., Hart, Huberta E., de Wolf, Cees, and Vos, Rimke C.

Published
2019

50. Individualised targets for insulin initiation in type 2 diabetes mellitus - The influence of physician and practice: A cross-sectional study in eight European countries

Author

Cardiovasculaire Epi Team 5, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Hart- Vaatziekten, HAG Zorginnovatieonderzoek, Boels, Anne Meike, Koning, Elwin, Vos, Rimke C., Khunti, Kamlesh, Rutten, Guy E.H.M., Cardiovasculaire Epi Team 5, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, HAG Hart- Vaatziekten, HAG Zorginnovatieonderzoek, Boels, Anne Meike, Koning, Elwin, Vos, Rimke C., Khunti, Kamlesh, and Rutten, Guy E.H.M.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results